Cargando…
Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples
Enveloped viruses, including the Human Immunodeficiency Virus-1 (HIV), incorporate host proteins such as human leucocyte antigens (HLA) into their envelope. Pre-existing antibodies against HLA, termed HLA antibodies, may bind to these surface proteins and reduce viral infectivity. Related evidence i...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987441/ https://www.ncbi.nlm.nih.gov/pubmed/35401581 http://dx.doi.org/10.3389/fimmu.2022.813412 |
_version_ | 1784682742552723456 |
---|---|
author | Suchard, Melinda S. Martinson, Neil Malfeld, Susan de Assis Rosa, Debbie Mackelprang, Romel D. Lingappa, Jairam Hou, Xuanlin Rees, Helen Delany-Moretlwe, Sinead Goldfein, Hadassa Ranchod, Heena Coetzee, David Otwombe, Kennedy Morris, Lynn Tiemessen, Caroline T. Savulescu, Dana M. |
author_facet | Suchard, Melinda S. Martinson, Neil Malfeld, Susan de Assis Rosa, Debbie Mackelprang, Romel D. Lingappa, Jairam Hou, Xuanlin Rees, Helen Delany-Moretlwe, Sinead Goldfein, Hadassa Ranchod, Heena Coetzee, David Otwombe, Kennedy Morris, Lynn Tiemessen, Caroline T. Savulescu, Dana M. |
author_sort | Suchard, Melinda S. |
collection | PubMed |
description | Enveloped viruses, including the Human Immunodeficiency Virus-1 (HIV), incorporate host proteins such as human leucocyte antigens (HLA) into their envelope. Pre-existing antibodies against HLA, termed HLA antibodies, may bind to these surface proteins and reduce viral infectivity. Related evidence includes macaque studies which suggest that xenoimmunization with HLA antigens may protect against simian immunodeficiency virus infection. Since HIV gp120 shows homology with class 2 HLA, including shared affinity for binding to CD4, class 2 HLA antibodies may influence HIV acquisition via binding to gp120 on the viral envelope. We conducted a nested case-control study on HIV serodiscordant couples, comparing the frequency of HLA antibodies among highly exposed persistently seronegative controls with those who went on to acquire HIV (HIV-seroconverters). We first performed low resolution HLA typing on 143 individuals who were HIV-infected at enrollment (index partners) and their corresponding sexual partners (115 highly exposed persistently seronegative individuals and 28 HIV-seroconverters). We then measured HLA class 1 and 2 antibodies in the highly exposed persistently seronegative individuals and HIV-seroconverters at early and late timepoints. We analyzed whether such antibodies were directed at HLA specificities of their HIV-infected index partners, and whether autoantibodies or complement-fixing class 2 HLA antibodies were present. Seventy-nine percent of highly exposed persistently seronegative individuals had HLA antibodies; 56% against class 1 and 50% against class 2 alleles. Half of the group of highly exposed persistently seronegative individuals, prior to seroconversion, expressed class 2 HLA antibodies, compared with only 29% of controls (p=0.05). HIV infection was a sensitizing event leading to de novo development of antibodies against HLA-A and HLA-B loci, but not against class 2 loci. HLA autoantibodies were present in 27% of highly exposed persistently seronegative individuals. Complement-fixing class 2 HLA antibodies did not differ significantly between highly exposed persistently seronegative individuals and seroconverters. In multivariable regression, presence of class 2 HLA antibodies at early timepoints was associated with reduced odds of HIV acquisition (odds ratio 0.330, confidence interval 0.112-0.976, p=0.045). These epidemiological data suggest that pre-existing class 2 HLA antibodies were associated with reduced odds of HIV acquisition. |
format | Online Article Text |
id | pubmed-8987441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89874412022-04-08 Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples Suchard, Melinda S. Martinson, Neil Malfeld, Susan de Assis Rosa, Debbie Mackelprang, Romel D. Lingappa, Jairam Hou, Xuanlin Rees, Helen Delany-Moretlwe, Sinead Goldfein, Hadassa Ranchod, Heena Coetzee, David Otwombe, Kennedy Morris, Lynn Tiemessen, Caroline T. Savulescu, Dana M. Front Immunol Immunology Enveloped viruses, including the Human Immunodeficiency Virus-1 (HIV), incorporate host proteins such as human leucocyte antigens (HLA) into their envelope. Pre-existing antibodies against HLA, termed HLA antibodies, may bind to these surface proteins and reduce viral infectivity. Related evidence includes macaque studies which suggest that xenoimmunization with HLA antigens may protect against simian immunodeficiency virus infection. Since HIV gp120 shows homology with class 2 HLA, including shared affinity for binding to CD4, class 2 HLA antibodies may influence HIV acquisition via binding to gp120 on the viral envelope. We conducted a nested case-control study on HIV serodiscordant couples, comparing the frequency of HLA antibodies among highly exposed persistently seronegative controls with those who went on to acquire HIV (HIV-seroconverters). We first performed low resolution HLA typing on 143 individuals who were HIV-infected at enrollment (index partners) and their corresponding sexual partners (115 highly exposed persistently seronegative individuals and 28 HIV-seroconverters). We then measured HLA class 1 and 2 antibodies in the highly exposed persistently seronegative individuals and HIV-seroconverters at early and late timepoints. We analyzed whether such antibodies were directed at HLA specificities of their HIV-infected index partners, and whether autoantibodies or complement-fixing class 2 HLA antibodies were present. Seventy-nine percent of highly exposed persistently seronegative individuals had HLA antibodies; 56% against class 1 and 50% against class 2 alleles. Half of the group of highly exposed persistently seronegative individuals, prior to seroconversion, expressed class 2 HLA antibodies, compared with only 29% of controls (p=0.05). HIV infection was a sensitizing event leading to de novo development of antibodies against HLA-A and HLA-B loci, but not against class 2 loci. HLA autoantibodies were present in 27% of highly exposed persistently seronegative individuals. Complement-fixing class 2 HLA antibodies did not differ significantly between highly exposed persistently seronegative individuals and seroconverters. In multivariable regression, presence of class 2 HLA antibodies at early timepoints was associated with reduced odds of HIV acquisition (odds ratio 0.330, confidence interval 0.112-0.976, p=0.045). These epidemiological data suggest that pre-existing class 2 HLA antibodies were associated with reduced odds of HIV acquisition. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8987441/ /pubmed/35401581 http://dx.doi.org/10.3389/fimmu.2022.813412 Text en Copyright © 2022 Suchard, Martinson, Malfeld, de Assis Rosa, Mackelprang, Lingappa, Hou, Rees, Delany-Moretlwe, Goldfein, Ranchod, Coetzee, Otwombe, Morris, Tiemessen and Savulescu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Suchard, Melinda S. Martinson, Neil Malfeld, Susan de Assis Rosa, Debbie Mackelprang, Romel D. Lingappa, Jairam Hou, Xuanlin Rees, Helen Delany-Moretlwe, Sinead Goldfein, Hadassa Ranchod, Heena Coetzee, David Otwombe, Kennedy Morris, Lynn Tiemessen, Caroline T. Savulescu, Dana M. Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples |
title | Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples |
title_full | Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples |
title_fullStr | Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples |
title_full_unstemmed | Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples |
title_short | Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples |
title_sort | alloimmunity to class 2 human leucocyte antigens may reduce hiv-1 acquisition – a nested case-control study in hiv-1 serodiscordant couples |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987441/ https://www.ncbi.nlm.nih.gov/pubmed/35401581 http://dx.doi.org/10.3389/fimmu.2022.813412 |
work_keys_str_mv | AT suchardmelindas alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT martinsonneil alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT malfeldsusan alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT deassisrosadebbie alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT mackelprangromeld alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT lingappajairam alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT houxuanlin alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT reeshelen alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT delanymoretlwesinead alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT goldfeinhadassa alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT ranchodheena alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT coetzeedavid alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT otwombekennedy alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT morrislynn alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT tiemessencarolinet alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples AT savulescudanam alloimmunitytoclass2humanleucocyteantigensmayreducehiv1acquisitionanestedcasecontrolstudyinhiv1serodiscordantcouples |